A Prospective Open Label Randomized Clinical Study of Compound Unani Formulation (Ustukhuddoos,Filfil Siyah,Aslussoos) in the Management of Iltihab-e-Tajaweef-e-Anaf Muzmin (Chronic Sinusitis).

Zahid Arfi, Razi Ahmad, Najibur Rahman, Tanwir Alam
{"title":"A Prospective Open Label Randomized Clinical Study of Compound Unani Formulation (Ustukhuddoos,Filfil Siyah,Aslussoos) in the Management of Iltihab-e-Tajaweef-e-Anaf Muzmin (Chronic Sinusitis).","authors":"Zahid Arfi, Razi Ahmad, Najibur Rahman, Tanwir Alam","doi":"10.46624/ajphr.2020.v8.i9.004","DOIUrl":null,"url":null,"abstract":"Tajaweef-e-Anaf (Sinusitis) has tremendous impact on public health. It is the 5 known case of population. Under such circumstances, the Unani medicine has proven its own importance regarding its efficacy, cost and minimal side effects. The present study was designed as an open label randomized clinical trial in successive patients with chronic sinusitis diagnosed on presentation, history and investigations. Sixty diagnosed patients of age between 15-60 years. Who belongs to inclusion criteria were registered, and compound Unani formulation (Ustukhuddoos, Filfil Siyah, Aslussoos) is given for 45 days. Complete physical examination & investigations of patients were done and follow-up planned prior of trial, 15 30 day and at the end of trial. Subjective objective and safety parameter recorded. On objective parameters, there are two sub headings, pathological investigation and radiological examination. In Radiological examination, Calculating by Chi-square p-Value is 0.001 which is significant. While in pathological investigation in TLC, Lymphocyte, Eosinophils “P” value is 0.001, which is very significant. Haemoglobin “P” value is 0.517 and Monocyte, “P” value 0.088 which is not significant.","PeriodicalId":233230,"journal":{"name":"American Journal of Pharmacy And Health Research","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Pharmacy And Health Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46624/ajphr.2020.v8.i9.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Tajaweef-e-Anaf (Sinusitis) has tremendous impact on public health. It is the 5 known case of population. Under such circumstances, the Unani medicine has proven its own importance regarding its efficacy, cost and minimal side effects. The present study was designed as an open label randomized clinical trial in successive patients with chronic sinusitis diagnosed on presentation, history and investigations. Sixty diagnosed patients of age between 15-60 years. Who belongs to inclusion criteria were registered, and compound Unani formulation (Ustukhuddoos, Filfil Siyah, Aslussoos) is given for 45 days. Complete physical examination & investigations of patients were done and follow-up planned prior of trial, 15 30 day and at the end of trial. Subjective objective and safety parameter recorded. On objective parameters, there are two sub headings, pathological investigation and radiological examination. In Radiological examination, Calculating by Chi-square p-Value is 0.001 which is significant. While in pathological investigation in TLC, Lymphocyte, Eosinophils “P” value is 0.001, which is very significant. Haemoglobin “P” value is 0.517 and Monocyte, “P” value 0.088 which is not significant.
复方Unani制剂(Ustukhuddoos,Filfil Siyah,Aslussoos)治疗Iltihab-e-Tajaweef-e-Anaf Muzmin(慢性鼻窦炎)的前瞻性开放标签随机临床研究
Tajaweef-e-Anaf(鼻窦炎)对公众健康有巨大影响。这是已知的5例人口病例。在这种情况下,Unani药物在功效、费用和副作用极小方面证明了其重要性。本研究是一项开放标签随机临床试验,在连续的慢性鼻窦炎患者诊断的表现,历史和调查。60例确诊患者年龄在15-60岁之间。对属于纳入标准的患者进行登记,并给予复方Unani制剂(Ustukhuddoos, Filfil Siyah, Aslussoos) 45天。在试验前、15 ~ 30天及试验结束时对患者进行完整的体格检查和调查,并计划随访。记录主观、客观和安全参数。在客观参数上,有两个小标题,病理调查和放射检查。在放射学检查中,卡方p值为0.001,具有显著性。病理检查中,淋巴细胞、嗜酸性粒细胞“P”值为0.001,非常显著。血红蛋白P值为0.517,单核细胞P值为0.088,差异无统计学意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信